These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 32910408

  • 1. Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants?
    Kartsios C, Lokare A, Osman H, Perrin D, Razaq S, Ayub N, Daddar B, Fair S.
    J Thromb Thrombolysis; 2021 May; 51(4):947-952. PubMed ID: 32910408
    [Abstract] [Full Text] [Related]

  • 2. Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants.
    Lewis P, Tharp JL.
    J Clin Pharm Ther; 2021 Apr; 46(2):519-523. PubMed ID: 33217032
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F, Temraz S.
    Clin Appl Thromb Hemost; 2021 Apr; 27():10760296211039288. PubMed ID: 34595937
    [Abstract] [Full Text] [Related]

  • 4. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M, Tang GH, Negri E, Rahhal H, Kreuziger LB, Pompilio CE, James P, Fralick M, AlHamzah M, Alomran F, Tseng E, Lim G, Lillicrap D, Carrier M, Áinle FN, Beckett A, da Costa BR, Thorpe K, Middeldorp S, Lee A, Cushman M, Jüni P.
    Trials; 2021 Mar 10; 22(1):202. PubMed ID: 33691765
    [Abstract] [Full Text] [Related]

  • 5. Management of cancer-associated venous thromboembolism - a case-based practical approach.
    Voigtlaender M, Langer F.
    Vasa; 2018 Feb 10; 47(2):77-89. PubMed ID: 29325495
    [Abstract] [Full Text] [Related]

  • 6. Venous thromboembolism and COVID-19: a case report and review of the literature.
    Bhatt H, Singh S.
    J Med Case Rep; 2020 Oct 15; 14(1):188. PubMed ID: 33054805
    [Abstract] [Full Text] [Related]

  • 7. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
    Bang SM, Kang JH, Hong MH, Ahn JS, Oh SY, Baek JH, Choi YJ, Shin SH, Kim YJ, Gil HY, Park HE, Lee J, Park EL.
    Clin Appl Thromb Hemost; 2021 Oct 15; 27():1076029620979575. PubMed ID: 33471574
    [Abstract] [Full Text] [Related]

  • 8. Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.
    Faggiano P, Bonelli A, Paris S, Milesi G, Bisegna S, Bernardi N, Curnis A, Agricola E, Maroldi R.
    Int J Cardiol; 2020 Aug 15; 313():129-131. PubMed ID: 32471650
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI, HEP-COVID Investigators.
    JAMA Intern Med; 2021 Dec 01; 181(12):1612-1620. PubMed ID: 34617959
    [Abstract] [Full Text] [Related]

  • 10. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X, Lin J.
    BMC Musculoskelet Disord; 2018 Sep 08; 19(1):322. PubMed ID: 30193575
    [Abstract] [Full Text] [Related]

  • 11. Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials.
    Brunetti ND, Tricarico L, Correale M, De Gennaro L, Santoro F, Ieva R, Di Biase M.
    J Thromb Thrombolysis; 2020 Aug 08; 50(2):305-310. PubMed ID: 31654194
    [Abstract] [Full Text] [Related]

  • 12. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M, Agnelli G, Del Toro-Cervera J, Klok FA, Rosovsky RP, Martin AC, Herold J, Tzoran I, Szmit S, Bertoletti L, Becattini C, Huisman MV.
    Thromb Haemost; 2020 Jul 08; 120(7):1128-1136. PubMed ID: 32365386
    [Abstract] [Full Text] [Related]

  • 13. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
    Chen DY, Tseng CN, Hsieh MJ, Lan WC, Chuang CK, Pang ST, Chen SW, Chen TH, Chang SH, Hsieh IC, Chu PH, Wen MS, Chen JS, Chang JW, See LC, Huang WK.
    JAMA Netw Open; 2021 Feb 01; 4(2):e2036304. PubMed ID: 33533929
    [Abstract] [Full Text] [Related]

  • 14. Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis.
    Yang M, Li J, Sun R, Wang Y, Xu H, Yang B, Wu X, Yu L.
    J Cancer Res Ther; 2019 Feb 01; 15(7):1541-1546. PubMed ID: 31939435
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
    Pernod G, Joly M, Sonnet B.
    J Med Vasc; 2020 Nov 01; 45(6S):6S17-6S23. PubMed ID: 33276939
    [Abstract] [Full Text] [Related]

  • 17. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
    Chang H, Rockman CB, Jacobowitz GR, Speranza G, Johnson WS, Horowitz JM, Garg K, Maldonado TS, Sadek M, Barfield ME.
    J Vasc Surg Venous Lymphat Disord; 2021 May 01; 9(3):597-604. PubMed ID: 33039545
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I, Elzouki AN.
    Vasc Health Risk Manag; 2020 May 01; 16():455-462. PubMed ID: 33223833
    [Abstract] [Full Text] [Related]

  • 20. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
    Bellmunt-Montoya S, Riera C, Gil D, Rodríguez M, García-Reyes M, Martínez-Carnovale L, Marrero C, Gil M, Ruiz-Rodríguez JC, Ferrer R, de Nadal M, Monreal M, Llagostera S.
    Eur J Vasc Endovasc Surg; 2021 Apr 01; 61(4):628-634. PubMed ID: 33583710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.